Wednesday, February 10, 2010, 7:25pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Antares Pharma Inc. (AIS)

At 5:00AM SGT: 1.12 USD   0.00 (0.00%)  
 MORE ON AIS 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ANTARES PHARMA INC (AMEX:AIS) Delayed quote dataEdit
Last Trade:1.12 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:1.12
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:2.50
Day's Range:N/A - N/A
52wk Range:0.30 - 1.35
Volume:0
Avg Vol (3m):327,119
Market Cap:91.52M
P/E (ttm):N/A
EPS (ttm):-0.152
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add AIS to Portfolio   Download Data

 HEADLINES 
•Skymark Research Initiates Independent Research Coverage on Antares Pharma, Inc.
GlobeNewswire (Wed, Feb 3)
•ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES' Patient-Friendly Injector for Growth Hormone Deficiency in Children
Business Wire (Wed, Feb 3)
•Antares Pharma Expands Executive Team and Appoints Pavan Handa as Senior Vice President of Business Development
Business Wire (Wed, Jan 20)
•Antares Pharma and Population Council Announce Positive Phase 2 Trial Results
Business Wire (Mon, Jan 11)
•Coverage initiated on Antares Pharma by Roth Capital
Briefing.com (Fri, Jan 8)
•Prospecting for Stocks: Antares Pharma
at Motley Fool (Tue, Dec 29)
•ANTARES PHARMA, INC. Financials
EDGAR Online Financials (Tue, Nov 17)
•ANTARES PHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 12)
•Antares Pharma, Inc. Earnings Call scheduled for 4:30 pm ET today
CCBN (Tue, Nov 10)
•ANTARES PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
EDGAR Online (Tue, Nov 10)
More Headlines for AIS...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.14
EPS Est (in 2 years) (Dec-10) :-0.07
Avg Rec (current)*:1.7
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Antares Pharma, Inc. operates as a specialty drug delivery/pharmaceutical company. Its drug delivery platforms include Advanced Transdermal Delivery gels, disposable pressure assisted auto injection systems, reusable needle-free injection systems,...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices